Patent · US Expired

Piperidylbenzimidazolinone derivatives

US4338323A · kind A · utility

15Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 1980
Grant dateJul 6, 1982
Priority date
Expiry dateNov 10, 2000

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Piperidylbenzimidazolinone derivatives of the formula: ##STR1## in which: R.sub.1 is lower alkyl, phenyl, halophenyl, lower alkylphenyl, lower alkoxyphenyl, methylenedioxyphenyl, ethylenedioxyphenyl, thienyl, furyl or pyridyl. PA1 R.sub.2 is R'.sub.1 COO-- or R'.sub.1 --COO--CH.sub.2 -- in which R'.sub.1 has the same meanings as R.sub.1, R.sub.1 and R'.sub.1 being the same or different, or R.sub.3 NH-- in which R.sub.3 is formyl, acetyl mesyl, carbamoyl, sulfamoyl or ethoxalyl. PA1 Z is hydrogen, lower-alkyl or lower alkenyl, and PA1 T is hydrogen, lower alkyl or lower alkoxy. These compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of autoimmune, allergic and antiinflammatory diseases and in the treatment of dyspnea especially asthmatic and bronchial dyspnea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.